Cyient denies developing flight test software for Boeing
Cyient denies developing flight test software for Boeing

Cyient denies developing flight test software for Boeing

Gayathri Udyawar Article rating: 4.8

Indian software engineers are being held response for faults in coding software of flight-test equipment for Boeing's 737 Max aircraft, by the US media. Two Indian IT firms HCL tech and Cyient have partnerships with Boeing.

Stocks approaching Ex-date this week
Stocks approaching Ex-date this week

Stocks approaching Ex-date this week

Gayathri Udyawar Article rating: 3.8

Other than profit and loss, important thing that investors watch out for are dividend or bonus shares. Read on to know which stocks will be on investor radar this week.

JSW Steel: CoC accepts Rs. 1,525 crore offer for Asian Colour
JSW Steel: CoC accepts Rs. 1,525 crore offer for Asian Colour

JSW Steel: CoC accepts Rs. 1,525 crore offer for Asian Colour

Gayathri Udyawar Article rating: 3.5

The Committee of Creditors (CoC) voted in favour of JSW’s Rs. 1,525 crore for the assets of debt-ridden Asian Colour Coated Ispat Limited, said news reports on Saturday. The company was the lone bidder for the assets.

Bombay Dyeing gains on receiving occupancy certificate
Bombay Dyeing gains on receiving occupancy certificate

Bombay Dyeing gains on receiving occupancy certificate

Gayathri Udyawar Article rating: 3.7

The textile to real estate developers has received Part Occupancy Certificate for Part 2 of its high-rise project located in Dadar-Naigaon. The document is significant for the company as it signifies that the building is fit for occupation.

Cox & Kings hits lower circuit
Cox & Kings hits lower circuit

Cox & Kings hits lower circuit

Gayathri Udyawar Article rating: 4.2

The company reported that it has defaulted payment towards maturity of its Unsecured Commercial Paper on June 26, 2019. For the Unsecured Commercial Paper aggregating to Rs. 200 crore, Rs. 50 crore was repaid and the balance amount of Rs. 150 crore has not been paid.

Sun Pharma, Chinese firm CMS to develop eye, arthritis drug
Sun Pharma, Chinese firm CMS to develop eye, arthritis drug

Sun Pharma, Chinese firm CMS to develop eye, arthritis drug

Gayathri Udyawar Article rating: 5.0

Sun Pharmaceutical Industries Limited has entered into an exclusive licensing agreement with a subsidiary of Chinese pharma major China Medical System Holdings (CMS) to develop and commercialise Cyclosporine A 0.09 per cent eye drops and Tildrakizumab a medication for psoriasis and psoriatic arthritis in Greater China.

Auto stocks rise, IT slips
Auto stocks rise, IT slips

Auto stocks rise, IT slips

Gayathri Udyawar Article rating: 5.0

Ahead of the expiry of derivative contracts for the month of June, Nifty Auto was up 1.37 per cent, fuelled by a unanimous surge in auto stocks led by Tata Motors and M&M on Thursday. 

Market close: Sensex zooms up 312 points
Market close: Sensex zooms up 312 points

Market close: Sensex zooms up 312 points

Gayathri Udyawar Article rating: 5.0

The benchmark indices Sensex and Nifty opened gap down on Tuesday and during the day scaled up continuously to post a steep gain. Reliance Industries and major private banks contributed the most to the index gains.

SBI Life dips 4 per cent on back of OFS
SBI Life dips 4 per cent on back of OFS

SBI Life dips 4 per cent on back of OFS

Gayathri Udyawar Article rating: 3.3

SBI Life Insurance Company Limited's promoter BNP Paribas Cardif has initiated an offer for sale (OFS) to sell 2.5 per cent equity shares of the company through separate windows on the exchanges.

RSS
First567810121314Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR